KAS
DNA icon

Kestra Advisory Services’s Ginkgo Bioworks DNA Stock Holding History

Kestra Advisory Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-565
Closed -$26.2K – 2630
2024
Q1 		$26.2K Buy
565
+93
+20% +$4.81K ﹤0.01% 2425
2023
Q4 		$31.9K Buy
472
+102
+28% +$6.25K ﹤0.01% 2240
2023
Q3 		$26.8K Buy
370
+88
+31% +$7.04K ﹤0.01% 2077
2023
Q2 		$21K Buy
+282
New +$16.7K ﹤0.01% 2079

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Kestra Advisory Services's DNA Position: Q2 2024 in Review

Kestra Advisory Services sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 565 shares — an estimated $26.2K sold.

Kestra Advisory Services first reported a position in DNA in Q2 2023 and held it in 4 quarters. The position peaked at $31.9K in Q4 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Kestra Advisory Services reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 565 Ginkgo Bioworks shares in Q2 2024, an estimated $26.2K.
  • Kestra Advisory Services first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 4 quarters.
  • Kestra Advisory Services's Ginkgo Bioworks position peaked at $31.9K in Q4 2023.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Kestra Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.